DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Erythrocin (Erythromycin) - Respiratory Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Respiratory Failure (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erythrocin (Erythromycin) where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Erythrocin side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-08

Patient: female, weighing 25.7 kg (56.5 pounds)

Reactions: Pancreatitis Acute, Respiratory Failure, Disseminated Intravascular Coagulation, Acidosis, Cardiac Arrest, Blood Pressure Decreased, Anuria

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Dosage: see image
    Indication: Pneumonia
    Start date: 2010-03-01
    End date: 2010-04-06

Amphotericin B
    Dosage: see image
    Indication: Pneumonia
    Start date: 2010-04-07
    End date: 2010-04-12

Erythrocin
    Dosage: ([2 in 1 day, after breakfast and supper (200 mg, 2 in 1 day, after breakfast and supper)] oral)
    Administration route: Oral
    Indication: Primary Ciliary Dyskinesia
    Start date: 2005-01-01
    End date: 2010-04-12

Other drugs received by patient: Midazolam; Clobazam; Tazobactam; Gabapentin; Natural Aluminum Silicate; Monoammonium; Valproate Sodium; Carbocisteine Lysine; Budesonide; Teicoplanin; Clonidine HCL; Antibiotics-Resistant Lactic Acid Bacteriae; Albumin Tannate; Minocycline Hydrochloride; Phenobarbital TAB; Ambroxol Hydrochloride; Doripenem Monohydrate; Ethyl Loflazepate; Pranlukast; Sodium Bromide



Possible Erythrocin side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-23

Patient: female, weighing 25.7 kg (56.5 pounds)

Reactions: Pancreatitis Acute, Vomiting, Disseminated Intravascular Coagulation, Acidosis, Heart Rate Decreased, Respiratory Failure, Abdominal Distension, Cardiac Arrest, Blood Pressure Decreased, Anuria

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
    Indication: Pneumonia
    Start date: 2010-03-01

Amphotericin B
    Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
    Indication: Pneumonia
    Start date: 2010-04-07
    End date: 2010-04-12

Erythrocin
    Dosage: (200 mg bid oral)
    Administration route: Oral
    Indication: Primary Ciliary Dyskinesia
    End date: 2010-04-12

Other drugs received by patient: Carbocisteine Lysine; Ambroxol Hydrochloride; Monoammonium Glycyrrhizinate; Gabapentin; Doripenem Monohydrate; Teicoplanin; Clobazam; Ethyl Loflazepate; Albumin Tannate; Antibiotics-Resistant Lactic Acid Bacteriae; Valproate Sodium; Minocycline Hydrochloride; Budesonide; Tazobactam; Phenobarbital TAB; Pranlukast; Sodium Bromide; Clonidine Hydrochloride; Natural Aluminum Silicate



Possible Erythrocin side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-13

Patient: female, weighing 27.5 kg (60.5 pounds)

Reactions: Arrhythmia, Uterine Cancer, Blood Potassium Decreased, Respiratory Failure, Ventricular Tachycardia, Chest Pain, COR Pulmonale, Respiratory Arrest, Depressed Level of Consciousness, Electrolyte Imbalance, Obstructive Airways Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Clarithromycin
    Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 2006-06-30
    End date: 2006-09-18

Clarithromycin
    Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 2006-09-19
    End date: 2006-10-16

Rythmodan / 00271801 / (Rythmodan) (Not Specified)
    Dosage: (300 mg, 300 mg (100 mg, 3 in 1 d) oral)
    Administration route: Oral
    Indication: Supraventricular Tachycardia
    End date: 2006-10-16

Acardi (Acardi) (Not Specified)
    Dosage: (5 mg, 5 mg ( 2.5 mg, 2 in 1 d) oral)
    Administration route: Oral
    Indication: Cardiac Failure Chronic
    End date: 2006-10-16

Erythrocin
    Dosage: (600 mg, 600 mg (200 mg, 3 in 1 d), oral
    Administration route: Oral
    Indication: Bronchiolitis
    Start date: 1992-01-01
    End date: 2006-06-29

Other drugs received by patient: Zolpidem Tartrate; Rabeprazole Sodium; Furosemide; Isosorbide Dinitrate; Radiotherapy; Theophylline; Ursodiol; Tiotropium Bromid Monohydrate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017